Patents by Inventor Catherine Elizabeth Margaret Allsopp

Catherine Elizabeth Margaret Allsopp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Malaria peptides
    Publication number: 20020136733
    Abstract: 8-11-Mer peptides are identified, from four Plasmodium falciparum antigens, circumsporozoite protein, thrombospondin-related anonymous protein, spirozoite hepatocyte binding antigen and liver-stage antigen-1, as actual or potential cytotoxic T lymphocyte epitopes for human leucocyte antigen class I molecules HLA-A2, HLA-B8, HA-B7 and HLA-B17. Vaccines for immunization against malaria contain these peptides or oligonucleotides coding for them. A method of inducing primary cytotoxic T lymphocyte responses to a chosen antigen or microorganism comprises incubating lymphocytes ex vivo with the chosen antigen or microorganism in the presence of keyhole limpet haemocyanin.
    Type: Application
    Filed: January 11, 2002
    Publication date: September 26, 2002
    Inventors: Adrian Vivian Sinton Hill, Michael Aidoo, Catherine Elizabeth Margaret Allsopp, Ajit Lalvani, Magdalena Plebanski, Hilton Carter Whittle